July 22, 2021
America faces a good news-bad news situation, according to the newly published annual report from the American Cancer Society.
July 19, 2021
Warm summer months usually provide a break from respiratory syncytial virus. But not this year.
July 13, 2021
I know some people who are brand loyal because they are hesitant to change. I, however, am not one of them. And I take that approach in prescribing biologics and biosimilars for my patients, too.
July 12, 2021
By David Charles, MD “I’m never coming back into the office again!” That’s how one of my patients responded after…
July 9, 2021
The admonition to the Institute for Clinical and Economic Review’s Beacon Hill economists should be quite simple: “Stay in your lane.”
July 8, 2021
Health plans are quietly cutting more and more medications from their list of approved drugs, narrowing patients’ treatment options.
July 6, 2021
Many people still equate migraine with “bad headaches.” But in fact, migraine is a chronic, debilitating disease that afflicts 47 million Americans, 75% of whom are women.
July 1, 2021
Californians in danger of a heart attack or stroke now have help reducing a key risk factor.
June 30, 2021
Which would you choose – $500 or the medication that effectively manages your condition? It’s a tough choice, but one that patients across the country now face.
June 24, 2021
Biosimilars offer more cancer treatment options at potentially lower prices. So why aren’t they more accessible?